Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach
about
Facilitating surveillance of pulmonary invasive mold diseases in patients with haematological malignancies by screening computed tomography reports using natural language processing.Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year periodIdentification of Molds by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass SpectrometryAntimicrobial stewardship in patients with cancer.Pharmacoeconomic assessment of therapy for invasive aspergillosis.Advancing the Field: Evidence for New Management Strategies in Invasive Fungal InfectionsConsensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs.A Pilot Study of a Computerized Decision Support System to Detect Invasive Fungal Infection in Pediatric Hematology/Oncology Patients.Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.Antifungal stewardship considerations for adults and pediatrics.Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.New pharmacological opportunities for the treatment of invasive mould diseases.Defining Invasive Fungal Infection Risk in Hematological Malignancies: A New Tool for Clinical Practice.Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of adult haematology patients in the UK.Epidemiology of invasive fungal disease in lymphoproliferative disorders.The burden of hospitalised fall-related injury in community-dwelling older people in Victoria: a database study.Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
P2860
Q34245656-4391D4C8-53EF-4BBE-A2C3-D4A10B069F34Q35794484-E152F1A6-45EE-47DB-833D-57B20CCCD139Q36180756-1207E31F-9112-43AA-95FF-EA16C89EE007Q38073198-A1F43A39-B04B-4DAC-81DA-1AC39C39B559Q38073334-C843C6AC-CDCC-4634-B1A0-3F9E0EE7B790Q38082740-1D70BD9F-AAFA-40A1-AB9A-6504B4374E89Q38284470-AB7EB547-590F-4A03-8D77-1E49C21EA048Q38453666-785B7838-9672-40A0-A5F1-488701DA2276Q38567637-D82C8B0D-FE4A-4FB7-A33B-76E08BD3116DQ38589279-9B0D6945-2C99-4E2C-9E16-04901BCE2F9BQ38620631-1C8B80D8-1BC2-4B0F-8B53-5373E4E421E5Q38944746-1405390B-50BD-481C-91DD-25BDEEE60717Q38993519-AC1C1AE9-701A-4F9E-AB84-2ECA9CDB7A9FQ39196770-118970D8-4537-433F-B92C-958B246B313AQ40273481-FF1A6115-BF5D-44C5-9785-BC53244D4126Q40366168-20446724-8718-4736-A0B9-B5C5E5825F46Q40515140-5F1021D1-2E80-4834-8462-16AFEF15AFC9Q41656144-E5534D06-092E-4D61-A06C-D38012FC9A60Q42910837-3FD3E40F-9BBA-4F33-AF49-7CCB61654DB9Q44797931-1ED041BC-D3B3-4BC7-BC77-3C9F598DA46DQ47804787-B1B9F40F-E062-4C65-9000-AC07DAE92218
P2860
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Attributable hospital cost and ...... an economic modeling approach
@ast
Attributable hospital cost and ...... an economic modeling approach
@en
Attributable hospital cost and ...... an economic modeling approach
@nl
type
label
Attributable hospital cost and ...... an economic modeling approach
@ast
Attributable hospital cost and ...... an economic modeling approach
@en
Attributable hospital cost and ...... an economic modeling approach
@nl
prefLabel
Attributable hospital cost and ...... an economic modeling approach
@ast
Attributable hospital cost and ...... an economic modeling approach
@en
Attributable hospital cost and ...... an economic modeling approach
@nl
P2093
P2860
P356
P1476
Attributable hospital cost and ...... an economic modeling approach
@en
P2093
A Munro Neville
C Orla Morrissey
Michael Dooley
Michelle R Ananda-Rajah
Tim Spelman
P2860
P304
P356
10.1128/AAC.01423-10
P407
P577
2011-02-28T00:00:00Z